BRISTOL-MYERS SQUIBB SPOKESPERSON - IMPLEMENTED A VOLUNTARY PAUSE TO REVIEW CLINICAL DATA ACROSS OUR ZOLA-CEL PROGRAM

Reuters · 1d ago

Please log in to view news